Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Debt / NOTE 1.500%10/0
-
Market price (% of par)
-
80.71%
-
Total 13F principal
-
$314,112,868
-
Principal change
-
+$310,112,868
-
Total reported market value
-
$260,461,734
-
Number of holders
-
24
-
Value change
-
+$257,240,914
-
Number of buys
-
23
Institutional Holders of AERIE PHARMACEUTICALS INC - NOTE 1.500%10/0 as of Q3 2020
As of 30 Sep 2020,
AERIE PHARMACEUTICALS INC - NOTE 1.500%10/0 was held by
24 institutional
bondholders
reporting positions in Form 13F filings.
These institutions reported holding
$314,112,868
in principal (par value) of the bond.
The largest 10 bondholders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), PFM Health Sciences, LP, CITADEL ADVISORS LLC, LAZARD ASSET MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, Nuveen Asset Management, LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Context Partners Fund, L.P., Context Capital Management, LLC, and MORGAN STANLEY.
This page lists
24
institutional bondholders reporting positions
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price (% of par)
|
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.